Optioncare therapy overview

The home of exceptional healthcare services

With nearly 40 years of experience, Option Care is one of the nation’s leading home infusion service providers.

Home Infusion Plus

Anti-Infectives Streamlines administrative burdens of care so home antibiotic infusions can start sooner.

• 0.05 CVC-related bloodstream infections (per 1,000 catheter days)1 • 98% rate of incident-free infusion encounters2 • 0.44% rate of unplanned antibiotic-related hospital readmissions3 • $1,623 estimated average cost avoidance per Option Care pharmacist intervention vs previous study results4

We support patients with complex and chronic conditions. Our signature services provide comprehensive clinical management at the patient’s home or our alternate treatment sites nationwide.

Nutrition Support

Immunoglobulin

Home nutrition support for patients with a broad range of conditions.

• Comprehensive parenteral nutrition (PN) support, with invaluable interventions • High-touch, personalized enteral nutrition (EN) services with the standards to support them • Our interventions prevent hospitalization and reduce costs5 • Our proactive approach reduced weaning time by one-third6

Comprehensive services that meet the specific needs of IG patients.

• Option Care PartnerPoint Clinical Management® helps improve outcomes from the start of therapy • Access to all available intravenous IG and subcutaneous IG therapies for customized, uninterrupted treatment • Quality care that reduces IG-related adverse drug reactions10 • Specialized care from IG trained nurses and IG pharmacists

Heart Failure Comprehensive services that meet the specific needs of patients with stage D heart failure.

• Customized treatment plans based on the protocols of the transplant/VAD center care team, palliative care program or hospice program • Smooth transition to home therapy with in-hospital education • Ongoing monitoring to help minimize exacerbation of symptoms and reduce hospital readmissions7,8 • 86% of patients meet their therapy goal9 • Dedicated team of heart failure clinicians

36+

Years of home infusion experience11

Specialized Therapies Bleeding Disorders Patients benefit from targeted interventions.

• Social worker support • Frequent, ongoing monitoring and nursing supports adherence • Lab monitoring and reporting to HTC for remote patients • Physical therapy coordination and consultation • Help obtaining equipment and protective supplies • Access to product support programs

96% High patient satisfaction12

1800+

infusion nurses, pharmasists and registered dietitians11

Management of complex conditions with a high level of detail and clinical expertise, no matter how large or small the patient population.

• Innovative suite of services designed to manage all aspects of care for emerging therapies • Customized protocol development maximizes clinical benefit • National presence allows broad access to patients who need treatment

170k+ Patients under our care each year13

Highly customized, high-quality home infusion Our customized care plans are built around the individual needs of patients and their physicians. Option Care assigns every patient an experienced, dedicated care team comprised of clinicians and coordination specialists.

Time-saving intake coordination

Longstanding support & education

Our experienced team of intake specialists coordinate insurance verification so treatment is not delayed.

Long-term relationships with infusion nurses ensure that each patient’s care and educational needs are completely met.

Individualized care plans

Clinical monitoring & reporting

Our clinicians help healthcare providers develop a personalized care plan for each patient based on therapeutic goals.

Our clinicians continuously monitor patients and keep healthcare providers informed with comprehensive reports.

References: 1. Review of Option Care patient data, December 2013-February 2014. Based on a review of 3,895 patients representing 204,253 catheter-days. 2. Review of Option Care patient data, October 2009-February 2011. Based on an average of 39,978 patients per month. 3. Review of Option Care patient data, February 2014. Based on a review of 48,750 anti-infective patients. 4. Retrospective review (August 2012-January 2013) of patients who received home infusions of parenteral vancomycin and aminoglycosides. Of 9,223 total patients, 257 were randomly selected and reviewed for pharmacist interventions performed. 5. Luszcz N, O’Neill M, Siddiqui T. Home nutrition support team interventions demonstrate improved clinical and financial outcomes. Poster presented at: Clinical Nutrition Week 2013; February 9-12, 2013; Phoenix, AZ. 6. Luszcz N, Barron A, Patel S. Positive outcomes demonstrated from PN weaning initiated by the dietitian of a home nutrition support team. Poster presented at: 2014 National Home Infusion Association Conference & Exposition; March 31-April 3, 2014; Orlando, FL. 7. Retrospective chart review of Option Care data collected January 1, 2004-December 31, 2008. 8. Joint Commission Quality Report Hospital. http://www.qualitycheck.org/QualityReport.aspx?hcoid=5503. Accessed February 26, 2015. 9. Data on file, Option Care.

10. Souayah N, Hasan A, Khan HMR, Yacoub HA, Jafri M. The safety profile of home infusion of intravenous immunoglobulin in patients with neuroimmunologic disorders. J Clin Neuromuscul Dis. 2011;12(4):S1-S10. 11. Option Care data on file, 2016. 12. September 2013-August 2014 patient satisfaction data. Survey of 1,649 patients. 13. Review of Option Care patient data, January-December 2013.

Contact us at 866.827.8203 (7:30 am - 5 pm CST) or visit optioncare.com for more information ©2017 Option Care Enterprises, Inc. All rights reserved. 17OC0080